Expected to clarify Planning Commission's stand on the issue today Planning Commission Deputy Chairman Montek Singh Ahluwalia on Sunday called on Prime Minister Manmohan Singh in the wake of the controversy over the Commission's Rs. 32 per capita per day definition of poverty line. He is expected to clarify the Commission's stand on the issue on Monday. The controversy broke out after an affidavit was filed by the Commission in the Supreme...
More »SEARCH RESULT
Planning Commission may finally have some idea about poor
-The Economic Times The Planning Commission, under a sustained attack from the Union Cabinet and the National Advisory Council over its affidavit to the Supreme Courtthat claimed that the rural poor can take care of his food, educational and health requirements with 25 a day, is expected to revise its stand on Monday. This follows a meeting between Planning Commission Deputy Chairman Montek Singh Ahluwalia and Prime Minister Manmohan Singh here...
More »To the hungry, god is bread by MS Swaminathan
The National Food Security Bill, 2011, designed to make access to food a legal right, is the last chance to convert Gandhiji's vision of a hunger-free India into reality. What Mahatma Gandhi said of the role of food in a human being's life in a 1946 speech at Noakhali, now in Bangladesh, remains the most powerful expression of the importance of making access to food a basic human right. Gandhiji also...
More »Bitter pill for Big Pharma by Bhupesh Bhandari
A committee headed by Planning Commission member Arun Maira, the former head of The Boston Consulting Group in India, wants all acquisitions of Indian pharmaceutical companies by foreigners to be scanned by the Competition Commission of India or CCI. The report will now be sent to Prime Minister Manmohan Singh and Planning Commission Deputy Chairman Montek Singh Ahluwalia. Prime Minister Singh is expected to take a final view on the...
More »Affordable medicine
-The Business Standard It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...
More »